Spirocyclic 2,6-Dioxopiperazine Derivatives
1
are uncorrected. H NMR spectra were recorded at 200, 300,
corresponding dioxopiperazine derivative 7a-d,g (0.25 mmol)
in dry CH3CN (2.5 mL). After 2 h of stirring at 50 °C, the
mixture was evaporated, the residue was dissolved in CH2Cl2
(20 mL), and the resulting solution was successively washed
with H2O (5 mL) and brine (5 mL), dried over Na2SO4, and
evaporated to dryness. The residue was purified by circular
chromatography, using 15-25% gradient of EtOAc in hexane
as eluant. Significant analytical and spectroscopic data of the
resulting dioxopiperazine derivatives 9a,d,g, 10a,b,d,g, 11a-
d,g, and 12a,g are summarized in Tables 4-7 of the Support-
ing Information.
or 400 MHz, using TMS as reference, and 13C NMR spectra
were recorded at 50, 75, or 100 MHz. The NMR spectra
assignment was based on COSY and HSQC spectra. ESI-MS
spectra were performed, in positive mode, using MeOH as
solvent.
General Procedure for the Synthesis of the r-Amino
Nitriles 4a-e,g,j-k. TEA (139.2 µL, 1 mmol) was added to a
solution of the corresponding amino acid derivative [H-Phe-
OMe‚HCl (2a), H-Pro-OMe‚HCl (2b), H-Trp-OMe‚HCl (2c),
H-Asp(OMe)-OMe‚HCl (2d), H-Asp(OBz)-OBz‚Tos (2e), H-Glu-
(OMe)-OMe‚HCl (2g), H-Ser(OMe)-OH‚HCl (2j)] (1 mmol) in
dry CH2Cl2 (20 mL). After 30 min of stirring at room temper-
ature under argon, cyclohexanone (103.6 µL, 1 mmol) was
added, and the stirring was maintained for 3 h. Then, the
solution was cooled to -23 °C, and ytterbium triflate (13.6 mg,
0.02 mmol) and trimethylsilyl cyanide (TMSCN, 187.7 µL, 1.5
mmol) were added. After being successively 1 h at -23 °C and
20 h at room temperature, the mixture was evaporated to
dryness. The residue was dissolved in CH2Cl2 (20 mL), and
the solution was washed with H2O (5 mL) and brine (5 mL),
dried over Na2SO4, and evaporated. The residue was purified
by flash chromatography, using 20-50% gradient of EtOAc
in hexane as eluant, to yield the corresponding R-amino nitrile
4a-e,g,j-k. Significant analytical and spectroscopic data of
these R-amino nitriles are summarized in Table 1 of the
Supporting Information.
General Procedure for the Hydration of the r-Amino
Nitriles 4(a-e,g,j-k). Synthesis of the r-Amino Car-
boxamides 6 and the (2S)-3,5-Dioxo-1,4-diazaspiro[5.5]-
undecane Derivatives 7. Concentrated H2SO4 (5 mL) was
added to a solution of the corresponding amino nitrile (4a-
e,g,j-k) (3 mmol) in CH2Cl2 (12 mL), and this mixture was
stirred at room temperature for 1 h. Afterward, the reaction
mixture was sequentially poured into ice, neutralized with
NH4OH, and extracted with CH2Cl2 (20 mL). The organic
extracts were successively washed with H2O (5 mL) and brine
(5 mL), dried over Na2SO4, and evaporated to dryness. The
residue was purified by flash chromatography, using 75-100%
gradient of EtOAc in hexane as eluant, to give the spiricyclic
2,6-dioxopiperazines 7a,d,g,j of higher Rf and the R-amino
carboxamides derivatives 6a-d,g. In the case of the tryp-
tophan-derived amino nitrile 4c, the hexahydropyrrolo[1′,2′,3′:
1,9a,9]imidazo[1,2-a]indole derivative 8 was the major product
of this reaction.15 Significant analytical and spectroscopic data
of these R-amino carboxamides 6a-d,g and of the (2S)-3,5-
dioxo-1,4-diazaspiro[5.5]undecane derivatives 7a,d,g,j are sum-
marized in Tables 2 and 3, respectively, and those of the
proline derivative 7b in Table 7 of the Supporting Information.
General Procedure for the Cyclization of the r-Amino
Carboxamides 6. Synthesis of the (2S)-3,5-Dioxo-1,4-
diazaspiro[5.5]undecane Derivatives 7. Method B. NaH
(60% dispersion in mineral oil; 6.6 mg, 0.28 mmol) was added
to a solution of the corresponding R-amino carboxamide (6a-
d,g) (0.25 mmol) in dry THF (7.5 mL), and this mixture was
stirred at room temperature for 1 h. Then, the solvent was
evaporated, the residue was dissolved in CH2Cl2 (20 mL), and
the resulting solution was successively washed with H2O (5
mL) and brine (5 mL), dried over Na2SO4, and evaporated to
dryness. The residue was purified by circular chromatography,
using 25-40% gradient of EtOAc in hexane as eluant. Sig-
nificant analytical and spectroscopic data of the resulting
dioxopiperazine derivatives 7a-d,g are summarized in Table
3 of the Supporting Information, except for those of the proline
derivative 7b which are summarized in Table 7.
General Procedure for the Alkylation of the Diox-
opiperazine Derivatives 7. Synthesis of (2S)-2,4-Disub-
tituted-3,5-dioxo-1,4-diazaspiro[5.5]undecane Deriva-
tives 9a,d,g, 10a,b,d,g, 11a-d,g, and 12a,g. Cs2CO3 (122.2
mg, 0.375 mmol) and the corresponding alkylating agent
(methyl iodide, benzyl bromide, methyl bromoacetate, or benzyl
bromoacetate, 0.375 mmol) were added to a solution of the
Synthesis of 2-Phenylmethyl-4-methyl-3,5-dioxo-1,4-
diazaspiro[5.5]undec-1-ene 13a. Cs2CO3 (25.59 mg, 0.078
mmol) was added to a solution of 9a (15 mg, 0.052 mmol) in
CH3CN (3 mL), and this mixture was stirred at 60 °C for 7
days. Afterward, the solvent was evaporated, the residue was
dissolved in CH2Cl2 (20 mL), and the resulting solution was
successively washed with H2O (5 mL) and brine (5 mL), dried
over Na2SO4, and evaporated to dryness. The residue was
purified by circular chromatography, using 10-12% gradient
of EtOAc in hexane as eluant: foam (10.3 mg, 70%); [R]20
D
-1.70 (c 0.8, MeOH); RP-HPLC [Novapak C18 (3,9 × 150 mm,
4µm), (A/B 50:50)] tR 16.51 min; 1H NMR (400 MHz, CDCl3) δ
(ppm) 1.42-1.94 [m, 10H, (7-11)-H], 2.05-2.11 (m, 2H, 7-Hax
and 11-Hax), 3.13 (s, 3H, 4-CH3), 4.01 (s, 2H, 2-CH2), 7.29 (m,
5H, Ph); 13C NMR (100 MHz, CDCl3) δ (ppm) 20.5 (C8 and C10),
25.4 (C9), 25.6 (4-CH3), 37.1 (C7 and C11), 40.5 (2-CH2), 65.5
(C6), 126.7, 128.4, 129.4 and 136.3 (Ph), 155.8 (C3), 157.1 (C2),
177.0 (C5); EM-ES m/z 285.0 (100) [M + 1]+. Anal. Calcd for
C17H20N2O2: C, 71.81; H, 7.09; N, 9.85. Found: C, 71.75; H,
7.40; N, 9.88.
Reactivity of the Asp-Derived Dioxopiperazine 10d
with NaOH. NaOH (1 N, 200 µL, 0.2 mmol) was added to a
solution of 10d (68.9 mg, 0.2 mmol) in 10:1 MeOH/H2O or 10:1
MeCN/H2O (3 mL). After 2 h of stirring at room temperature,
the mixture was evaporated, the residue was dissolved in H2O
(4 mL), and the resulting solution was washed with CH2Cl2
(12 mL). The aqueous solution was acidified with 1 N HCl to
pH 3, then the mixture was extracted with EtOAc (3 × 12 mL).
The organic extracts were dried over Na2SO4 and evaporated
to dryness. The residue was purified by radial chromatography
using 2-30% gradient of MeOH in CH2Cl2 as eluant, yielding
the dioxopiperazine derivative 10f (19.2 mg, 29%) and the
opened compound 14 (34.2 mg, 47%) in the case of the reaction
in MeOH/H2O, and 15 (64.4 mg, 89%) in the case of the
reaction in MeCN/H2O.
N-[1-(Methoxycarbonyl)cyclohexyl]aspartic acid ben-
zyl amide (14): amorphous solid (34.2 mg, 47%); [R]20D +2.75
(c 1, MeOH); RP-HPLC [Novapak C18 (3.9 × 150 mm, 4µm),
(A/B 30:70)] tR 3.98 min; 1H NMR (200 MHz, DMSO-d6) δ
(ppm) 1.15-1.84 (m, 10H, cyclohexyl), 2.22 [(dd, 1H, J ) 7.5
and 14.5 Hz, 3-H (Asp)], 2.38 [(dd, 1H, J ) 5 and 14.5 Hz,
3-H(Asp)], 3.33 [dd, 1H, 2-H(Asp)], 3.50 (s, 3H, OCH3), 4.17
(d, 1H, J ) 6 Hz, CH2-Ph), 4.34 (d, 1H, J ) 6 Hz, CH2-Ph),
7.26 (m, 5H, Ph), 8.70 (bs, 1H, NH); 13C NMR (50 MHz, DMSO-
d6) δ (ppm) 22.0 and 22.3 [C3 and C5 (cyclohexyl)], 25.2 [C4
(cyclohexyl)], 32.3 and 34.9 [C2 and C6 (cyclohexyl)], 40.1 (C3),
42.0 (CH2-Ph), 53.6 (C2), 126.7, 127.2, 128.2 and 139.5 (Ph),
171.0 (C1), 174.7 (CO2CH3); EM-ES m/z 363.3(100) [M + 1]+.
Anal. Calcd for C19H26N2O5: C, 62.97; H, 7.23; N, 7.73. Found
: C, 63.21; H, 7.44; N, 7.59.
N-[1-(Carboxyl)cyclohexyl]-Asp(OMe) benzyl amide
(15): amorphous solid (64.4 mg, 89%); [R]20D -0.84 (c 1, MeOH);
RP-HPLC [Novapak C18 (3.9 × 150 mm, 4 µm), (A/B 30:70)] tR
1.85 min; 1H NMR (200 MHz, acetone-d6) δ 1.18-2.06 (m, 10H,
cyclohexyl), 2.63 [dd, 1H, J ) 6 and 14.5 Hz, 3-H (Asp)], 2.76
[dd, 1H, J ) 5 and 14.5 Hz, 3-H (Asp)], 3.65 [dd, 1H, 2-H (Asp)],
3.51 (s, 3H, OCH3), 4.33 (d, 1H, J ) 6 Hz, CH2-Ph), 4.43 (d,
1H, J ) 6 Hz, CH2-Ph), 7.24 (m, 5H, Ph), 8.02 (bs, 1H, NH);
13C NMR (50 MHz, acetone-d6) δ 23.2 (C3 and C5 cyclohexyl),
26.6 (C4 cyclohexyl), 34.0 and 35.1 (C2 and C6 cyclohexyl), 38.7
(C3), 44.2 (CH2-Ph), 53.9 (C2), 126.8, 127.4, 128.2 and 139.6
J. Org. Chem, Vol. 70, No. 9, 2005 3665